What You Will Learn in This Article

Why B-cell lymphoma is the dominant type in the orbit and ocular adnexa
The specific subtypes of B-cell lymphoma affecting the orbit — with their relative frequencies
The classic clinical presentation of orbital lymphoma — the “salmon patch” and proptosis
Sites affected — orbit, conjunctiva, eyelid, lacrimal gland
How orbital lymphoma is diagnosed — imaging, biopsy, and immunohistochemistry
The association between MALT lymphoma and Chlamydia psittaci
Staging, treatment, and prognosis of ocular adnexal lymphoma
The broader classification of Non-Hodgkin’s Lymphoma and where orbital types fit
High-yield exam facts, mnemonics, and the most common exam traps
5 original practice MCQs to test yourself immediately

📖 Introduction: Why This Topic Matters in Exams

A 60-year-old woman presents with a painless, slowly progressive swelling of her right upper eyelid for the past 3 months. On examination, you note a salmon-pink, fleshy subconjunctival mass in the fornix. There is mild proptosis. The mass is non-tender and does not transilluminate. MRI shows a homogeneous enhancing mass moulding around the globe. Biopsy reveals sheets of small lymphoid cells with a characteristic immunophenotype.

This is the classic presentation of ocular adnexal lymphoma (OAL) — the most common primary orbital malignancy in adults — and in over 90% of cases, it is a B-cell Non-Hodgkin’s Lymphoma.

Examiners test this topic in multiple ways: “Most common orbital lymphoma?”, “Most common primary orbital malignancy in adults?”, “What is the salmon patch sign?”, “Which organism is associated with MALT lymphoma of the orbit?”, “What is the most common subtype of OAL?” This article gives you complete command of all these angles.

🔬 Section 1 — Non-Hodgkin’s Lymphoma: Classification Overview

To understand orbital lymphoma, you first need to place it within the broader NHL classification framework. This is tested in integrated questions that bridge ophthalmology and medicine.

Hodgkin’s vs Non-Hodgkin’s Lymphoma

Feature	Hodgkin’s Lymphoma (HL)	Non-Hodgkin’s Lymphoma (NHL)
Reed-Sternberg cells	Present (pathognomonic)	Absent
Spread	Contiguous (node to node)	Non-contiguous, unpredictable
Extranodal involvement	Rare	Common
Orbital involvement	Extremely rare	Common
B symptoms	More common	Less common
Prognosis	Generally better	Variable — depends on subtype

Key point: Orbital lymphoma is almost always NHL, not Hodgkin’s. If an MCQ asks about orbital lymphoma, think NHL immediately.

NHL Classification — B-cell vs T-cell vs NK-cell

The WHO classification of NHL divides lymphomas by cell of origin:

B-cell NHL (~85–90% of all NHL):

Diffuse Large B-Cell Lymphoma (DLBCL) — most common NHL overall
Follicular Lymphoma
Extranodal Marginal Zone B-cell Lymphoma (EMZL / MALT) — most common in the orbit
Mantle Cell Lymphoma
Burkitt Lymphoma
Small Lymphocytic Lymphoma / CLL

T-cell NHL (~10–15% of all NHL):

Peripheral T-cell lymphoma
Anaplastic Large Cell Lymphoma
Mycosis fungoides / Sézary syndrome

NK-cell NHL (<1%):

Extranodal NK/T-cell lymphoma, nasal type

Orbital proportion: B-cell NHL accounts for >90% of all ocular adnexal lymphomas. T-cell and NK-cell orbital lymphomas are rare and occur predominantly in Asian populations.

🔬 Section 2 — Extranodal Marginal Zone Lymphoma (MALT Lymphoma): The Most Common Orbital Subtype

What Is MALT Lymphoma?

MALT stands for Mucosa-Associated Lymphoid Tissue. MALT lymphoma (formally: Extranodal Marginal Zone B-cell Lymphoma of MALT type, EMZL) arises from B-lymphocytes in mucosa-associated lymphoid tissue at extranodal sites.

Classic sites of MALT lymphoma:

Stomach — most common overall; associated with H. pylori
Orbit / Ocular adnexa — most common orbital lymphoma
Salivary glands — associated with Sjögren’s syndrome
Thyroid — associated with Hashimoto’s thyroiditis
Lung
Skin

Exam pearl: MALT lymphoma of the stomach → associated with Helicobacter pylori. MALT lymphoma of the orbit → associated with Chlamydia psittaci (in some geographic regions, especially Europe and Asia). These pathogen associations are high-yield.

Frequency of B-cell Subtypes in the Orbit

Subtype	Approximate Frequency in OAL
Extranodal Marginal Zone (MALT)	50–70% — most common
Follicular Lymphoma	10–20%
Diffuse Large B-Cell Lymphoma (DLBCL)	10–15% — most aggressive
Mantle Cell Lymphoma	~5%
Small Lymphocytic Lymphoma	~5%

🔬 Section 3 — Sites of Ocular Adnexal Lymphoma

OAL can arise in any of the following locations — all are considered “ocular adnexa” or orbital structures:

Site	Frequency	Key Feature
Orbit (extraconal/intraconal fat)	Most common site overall	Proptosis; moulding sign on imaging
Conjunctiva	Very common	Classic “salmon patch” appearance
Eyelid	Common	Painless lid swelling; ptosis
Lacrimal gland	Less common	Lacrimal fossa mass; “S-shaped” ptosis

The “Salmon Patch”: The conjunctival form of OAL produces a characteristic salmon-pink, fleshy, painless subconjunctival mass — typically in the inferior or superior fornix. This colour results from the vascular stroma of the lymphomatous infiltrate. It is pathognomonic enough to be called the “salmon patch sign” and is one of the most tested clinical signs in orbital disease.

🏥 Section 4 — Clinical Presentation of Orbital Lymphoma

Symptoms and Signs

Symptoms:

Painless, slowly progressive proptosis (most common)
Eyelid swelling or ptosis
Diplopia (if extraocular muscles are involved)
Decreased vision (if optic nerve compressed)
Conjunctival redness or mass (in conjunctival form)
Occasionally: epiphora (if lacrimal drainage system is affected)

Signs:

Proptosis — axial (forward displacement of the globe)
“Salmon patch” — pathognomonic pinkish conjunctival mass
Moulding sign on MRI — lymphoma characteristically wraps around and moulds to the shape of the globe and orbital structures (unlike other orbital tumours that displace them)
Painless lacrimal gland enlargement — if lacrimal gland involved; produces S-shaped ptosis
Rubbery, firm consistency on palpation (when accessible)

Age and Demographics

Peak incidence: 5th–7th decade (50–70 years)
Slightly more common in women
Bilateral in approximately 10–15% of cases — important prognostic indicator
Association with systemic NHL in 20–35% of cases (i.e., orbital lymphoma can be the presenting manifestation of systemic disease)

🧪 Section 5 — Diagnosis of Orbital Lymphoma

Imaging

CT scan of orbit:

Homogeneous, well-defined, isodense mass
Moulds around globe (unlike cavernous haemangioma which compresses)
No bony erosion (unlike malignant tumours — bony destruction is rare in lymphoma)
Lacrimal gland enlargement if lacrimal form

MRI orbit (preferred for soft tissue detail):

Isointense to muscle on T1
Slightly hyperintense on T2
Homogeneous enhancement with gadolinium
“Moulding sign” — lymphoma drapes around the globe and orbital structures rather than displacing them; this is characteristic and distinguishes it from other orbital masses

Biopsy — The Definitive Investigation

Incisional biopsy is the gold standard for diagnosis
Fresh tissue must be sent for:
- Histopathology — morphology of cells
- Immunohistochemistry (IHC) — cell surface markers
- Flow cytometry — immunophenotyping
- Cytogenetics / FISH — chromosomal translocations

Immunohistochemistry Panel for B-cell OAL

B-cell lymphomas are characterised by expression of B-cell markers:

CD20 — positive (key marker; also the target of rituximab)
CD79a — positive
CD3 — negative (T-cell marker)
Bcl-2 — positive in follicular lymphoma
CD10 — positive in follicular lymphoma and DLBCL (germinal centre type)
Ki-67 (MIB-1) — proliferation index; higher in aggressive lymphomas

Exam pearl: CD20 positivity is the hallmark of B-cell lymphoma and the reason Rituximab (anti-CD20 monoclonal antibody) is effective treatment. This connection between marker and targeted therapy is heavily tested.

Systemic Staging

Once OAL is diagnosed, systemic staging is mandatory:

PET-CT scan — whole-body staging; most sensitive
CT chest/abdomen/pelvis — lymph node assessment
Bone marrow biopsy — for systemic spread
LDH, β2-microglobulin — prognostic markers
Ann Arbor Staging — used for lymphoma staging (Stage I–IV)

💊 Section 6 — Treatment of Orbital Lymphoma

Low-Grade OAL (MALT, Follicular) — Localised (Stage IE)

Radiation therapy — the primary treatment:

External beam radiotherapy (EBRT)
Dose: 24–36 Gy for indolent lymphomas
Excellent local control rates (>90%)
Well-tolerated but side effects include: dry eye, cataract, radiation retinopathy

Antibiotic therapy (for MALT lymphoma associated with C. psittaci):

Doxycycline — first-line antibiotic; causes regression of MALT lymphoma in C. psittaci-positive cases
Works by eliminating the antigenic stimulus (the bacteria) driving lymphoma proliferation
Analogous to H. pylori eradication causing gastric MALT regression

High-yield connection: Gastric MALT + H. pylori → treated with H. pylori eradication (triple therapy). Orbital MALT + C. psittaci → treated with doxycycline. Both are examples of antigen-driven lymphoma regression through antibiotic treatment.

High-Grade OAL (DLBCL) — Aggressive Lymphoma

R-CHOP chemotherapy — Rituximab + Cyclophosphamide + Doxorubicin + Vincristine + Prednisolone
Rituximab targets CD20 on B-cell surface
Combined with radiotherapy for localised disease

Bilateral or Systemic Disease

Systemic chemotherapy ± rituximab
Radiation to the orbit as adjunct
Consider autologous stem cell transplant in relapsed/refractory cases

🎯 High-Yield Exam Facts

These are the specific facts that appear repeatedly across NEET PG, USMLE, AIIMS and FMGE papers.

🔴 Most common orbital NHL = B-cell lymphoma — accounts for >90% of all ocular adnexal lymphomas
🔴 Most common specific subtype = MALT lymphoma (Extranodal Marginal Zone B-cell Lymphoma) — 50–70% of all OAL
🔴 Most common primary orbital malignancy in adults = Lymphoma — surpassing all other orbital tumours in the adult population
🔴 Salmon patch sign = pathognomonic conjunctival presentation — salmon-pink, fleshy, painless subconjunctival mass in the fornix
🔴 Moulding sign on MRI — orbital lymphoma wraps around the globe; does not displace it; distinguishes lymphoma from other orbital masses
🟠 MALT lymphoma of the orbit → associated with Chlamydia psittaci — especially in Italian and Asian populations; treated with doxycycline
🟠 MALT lymphoma of the stomach → associated with H. pylori — treated with H. pylori eradication; both are antigen-driven lymphomas
🟠 B-cell lymphoma marker = CD20 — target of rituximab (anti-CD20 monoclonal antibody); positive in MALT, follicular, DLBCL
🟠 DLBCL = most aggressive subtype of OAL — treated with R-CHOP ± radiotherapy; poor prognosis compared to MALT
🟠 Orbital lymphoma is bilateral in 10–15% — bilateral orbital lymphoma strongly suggests systemic disease
🟡 Most common orbital tumour in children = Rhabdomyosarcoma — not lymphoma; the adult vs paediatric distinction is a classic trap
🟡 Most common orbital tumour in adults overall = Cavernous haemangioma — but most common malignant/primary orbital malignancy in adults = lymphoma
🟡 No bony erosion on CT — characteristic of orbital lymphoma; bony erosion suggests lacrimal gland carcinoma or metastasis
🟡 T-cell and NK-cell orbital lymphomas are rare — more common in Asian populations; NK/T-cell lymphoma associated with EBV infection

🧠 Mnemonics & Memory Tricks

Mnemonic 1: “MALT = Most common Adnexal Lymphoma Type” MALT lymphoma = Mucosa-Associated Lymphoid Tissue = the Most common Adnexal Lymphoma Type in the orbit Use it for: Locking in both the name and the fact that it is the most common subtype in one phrase

Mnemonic 2: Orbital lymphoma clinical features — “SPAM” Salmon patch (conjunctival sign) Proptosis (painless, progressive) Adult (peak 5th–7th decade) Moulding sign on MRI Use it for: Recalling the four key clinical/imaging features of orbital lymphoma in clinical scenario MCQs

Mnemonic 3: MALT lymphoma organisms — “Stomach = H, Orbit = C” Stomach MALT → H. pylori Orbit MALT → Chlamydia psittaci Use it for: The two most tested pathogen-lymphoma associations; remember S→H and O→C

Mnemonic 4: B-cell lymphoma markers — “CD20 = B-cell, CD3 = T-cell, CD56 = NK-cell” 20 for B (B comes before T, 20 comes before 3) 3 for T (T is the 20th letter… no — just remember CD3 = T-cell) 56 for NK (NK cells are natural killers — think “56 kills”) Use it for: Immunohistochemistry questions about identifying lymphoma type from marker expression

Mnemonic 5: Most common orbital tumours by age — “Children = Rhabdo, Adults = Lymphoma (malignant), Cavernous (benign)” Rhabdomyosarcoma → children (most common orbital malignancy in children) Lymphoma → adults (most common primary orbital malignancy in adults) Cavernous haemangioma → adults (most common benign orbital tumour in adults) Use it for: The age-based orbital tumour hierarchy — a perennial exam comparison question

⚠️ Common Mistakes Students Make

❌ Mistake: “The most common orbital lymphoma is T-cell or NK-cell type” ✅ Reality: B-cell lymphoma accounts for >90% of all ocular adnexal lymphomas worldwide. T-cell and NK-cell orbital lymphomas are rare (<5% combined) and are more prevalent in Asian populations. In any MCQ asking about orbital NHL type without specifying geography or specific subpopulation, B-cell is always the answer. 📝 Exam trap: Options for T-cell and NK-cell are placed in MCQs to test whether students know the overwhelming predominance of B-cell type. The correct answer is B-cell in virtually every standard exam context.

❌ Mistake: “Orbital lymphoma always causes bony erosion visible on CT” ✅ Reality: Orbital lymphoma characteristically does NOT cause bony erosion. It is a soft tissue infiltrate that moulds around structures without destroying bone. Bony erosion on orbital CT should make you think of lacrimal gland carcinoma, metastasis, sinus malignancy invading the orbit, or myeloma — not lymphoma. The absence of bone destruction is a key radiological distinguishing feature. 📝 Exam trap: “A CT scan shows an orbital mass with bony erosion — what is the most likely diagnosis?” — Lymphoma is WRONG here. Think lacrimal gland carcinoma or metastasis.

❌ Mistake: “Orbital lymphoma presents with pain and rapid progression” ✅ Reality: Orbital lymphoma is characteristically painless and slowly progressive — this indolent behaviour is one of its defining clinical features (especially for low-grade MALT type). Rapid progression, pain, and inflammation suggest a more aggressive orbital process such as orbital cellulitis, orbital pseudotumour (idiopathic orbital inflammation), or high-grade DLBCL. The painless nature of OAL is tested repeatedly. 📝 Exam trap: A clinical scenario describes a “painful” orbital mass — this argues against typical low-grade OAL and suggests pseudotumour or infection instead.

❌ Mistake: “Most common primary orbital malignancy in adults is rhabdomyosarcoma” ✅ Reality: Rhabdomyosarcoma is the most common primary orbital malignancy in children (under 15 years). In adults, the most common primary orbital malignancy is lymphoma. This age-based distinction is one of the most frequently confused facts in orbital oncology. 📝 Exam trap: “Most common orbital malignancy” without specifying age → answer is lymphoma (adults predominate in most populations). If question specifies children → rhabdomyosarcoma.

❌ Mistake: “Rituximab works by killing B-cells through complement alone” ✅ Reality: Rituximab (anti-CD20 monoclonal antibody) kills B-cells through three mechanisms: (1) complement-dependent cytotoxicity (CDC), (2) antibody-dependent cell-mediated cytotoxicity (ADCC), and (3) direct induction of apoptosis. The CD20 antigen does not internalise after antibody binding, making it an excellent therapeutic target. Understanding this mechanism explains why CD20 positivity on biopsy predicts rituximab sensitivity. 📝 Exam trap: MCQs on monoclonal antibody mechanisms — rituximab targets CD20, not CD19 (blinatumomab) or CD52 (alemtuzumab). CD20 = B-cells = rituximab is the chain to remember.

🔗 How This Topic Connects to Others

Mastering orbital lymphoma connects directly to these high-yield topics across multiple subjects:

Orbital tumours classification — The complete hierarchy of orbital tumours (vascular: cavernous haemangioma; neural: optic nerve glioma, meningioma; lacrimal: pleomorphic adenoma, adenoid cystic carcinoma; lymphoid: lymphoma) is a recurring exam framework in ophthalmology
MALT lymphoma — Gastric type — The H. pylori connection and antibiotic-induced regression is the gastroenterology parallel; both gastric and orbital MALT lymphomas follow the same antigen-driven pathogenesis
Non-Hodgkin’s Lymphoma — General Medicine — NHL classification, Ann Arbor staging, B symptoms, LDH as prognostic marker, and R-CHOP chemotherapy are all tested in internal medicine and oncology papers
Orbital pseudotumour (Idiopathic Orbital Inflammation) — The most important differential diagnosis for orbital lymphoma; pseudotumour is painful and responds dramatically to steroids, while lymphoma is painless and does not respond to steroids
Sjögren’s syndrome and MALT — Sjögren’s patients have a 44-fold increased risk of developing MALT lymphoma (especially salivary gland MALT); connects rheumatology to oncology
Immunohistochemistry markers — CD20 for B-cells, CD3 for T-cells, CD56 for NK cells — connects to haematology, pathology, and targeted therapy MCQs across all exam systems

❓ The MCQ That Started This — Fully Explained

Question: Most common type of Non-Hodgkin’s Lymphoma in the orbit:

A. B-cell
B. T-cell
C. NK-cell
D. Plasma cell

✅ Correct Answer: A. B-cell

Why correct: B-cell Non-Hodgkin’s Lymphoma accounts for over 90% of all ocular adnexal lymphomas. The most common specific subtype is Extranodal Marginal Zone B-cell Lymphoma (MALT lymphoma), which represents 50–70% of all orbital lymphomas. B-cell lymphomas express CD20 (the target of rituximab) and arise from mature B-lymphocytes at extranodal mucosa-associated sites. The orbital and periorbital tissues, rich in lymphoid tissue, are a classic site for MALT-type B-cell lymphoma.

Why B is wrong: T-cell lymphomas account for less than 5% of ocular adnexal lymphomas. They are rare in the orbit and more commonly occur in the skin (mycosis fungoides), lymph nodes, and gastrointestinal tract. While T-cell OAL does exist, it is far less common than B-cell type in any standard exam context.

Why C is wrong: NK-cell lymphomas of the orbit are extremely rare — they constitute less than 1% of OAL. NK/T-cell lymphoma (nasal type) is associated with EBV infection and occurs predominantly in Asian populations, but even in these populations, B-cell lymphoma remains the most common orbital NHL subtype.

Why D is wrong: Plasma cell tumours (plasmacytomas and multiple myeloma with orbital involvement) are classified separately from NHL in modern classifications. They represent a distinct pathological entity. While myeloma can involve the orbit, it is not classified as a type of Non-Hodgkin’s Lymphoma and is not the most common type of orbital lymphoid malignancy.

📝 Test Your Understanding — 5 Practice MCQs

Q1. A 62-year-old woman presents with a painless, salmon-pink fleshy mass in the inferior conjunctival fornix of her left eye. The mass has grown slowly over 4 months. Biopsy shows small lymphoid cells positive for CD20 and negative for CD3. What is the most likely diagnosis?

A. Conjunctival squamous cell carcinoma
B. Extranodal Marginal Zone B-cell Lymphoma (MALT lymphoma)
C. T-cell orbital lymphoma
D. Orbital rhabdomyosarcoma

✅ **B. Extranodal Marginal Zone B-cell Lymphoma (MALT lymphoma)** — The clinical picture is classic for conjunctival OAL: painless, slowly progressive, salmon-pink mass in the fornix (salmon patch sign) in an elderly patient. CD20 positivity confirms B-cell lineage. CD3 negativity excludes T-cell lymphoma. MALT is the most common specific subtype of orbital NHL. Rhabdomyosarcoma occurs in children and presents much more aggressively with rapid proptosis.

Q2. An MRI orbit of a patient with proptosis shows a homogeneous, enhancing soft tissue mass that wraps around the globe without displacing it. There is no bony erosion. Which of the following orbital conditions is this appearance most characteristic of?

A. Cavernous haemangioma
B. Orbital lymphoma
C. Lacrimal gland adenoid cystic carcinoma
D. Orbital cellulitis

✅ **B. Orbital lymphoma** — The “moulding sign” — where the mass drapes around the globe conforming to its shape rather than displacing it — is characteristic of orbital lymphoma. Cavernous haemangioma is well-circumscribed, intraconal, and displaces structures rather than moulding. Adenoid cystic carcinoma is aggressive with perineural invasion and typically causes pain. Orbital cellulitis is associated with proptosis, lid oedema, pain, and fever — not a discrete mass on MRI.

Q3. Orbital MALT lymphoma has been found to be associated with infection by which organism in some geographic regions?

A. Helicobacter pylori
B. Chlamydia trachomatis
C. Chlamydia psittaci
D. Epstein-Barr virus

✅ **C. *Chlamydia psittaci*** — Orbital MALT lymphoma is associated with *Chlamydia psittaci* infection in certain geographic regions (particularly Italy, Austria, and parts of Asia). This association has led to the use of doxycycline as an antibiotic treatment that can induce regression of the lymphoma. *H. pylori* is associated with gastric MALT, not orbital MALT. *EBV* is associated with NK/T-cell lymphoma (nasal type) and Burkitt lymphoma. *C. trachomatis* causes trachoma and urogenital infections, not orbital lymphoma.

Q4. A patient with orbital B-cell DLBCL is planned for systemic chemotherapy. The regimen includes a monoclonal antibody targeting a B-cell surface antigen. Which antigen is targeted and what is the drug?

A. CD3 — OKT3
B. CD52 — Alemtuzumab
C. CD20 — Rituximab
D. CD19 — Blinatumomab

✅ **C. CD20 — Rituximab** — B-cell lymphomas (including DLBCL and MALT) express CD20 on their surface. Rituximab is a chimeric anti-CD20 monoclonal antibody that depletes B-cells via complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and direct apoptosis induction. R-CHOP (Rituximab + CHOP chemotherapy) is the standard treatment for aggressive B-cell lymphomas including DLBCL. CD3 is a T-cell marker; CD52 is targeted by alemtuzumab for CLL; CD19 is targeted by blinatumomab for ALL.

Q5. Which of the following statements about orbital lymphoma is INCORRECT?

A. It is the most common primary orbital malignancy in adults
B. It characteristically causes bony erosion visible on CT scan
C. The most common subtype is Extranodal Marginal Zone B-cell Lymphoma
D. The conjunctival form presents with a salmon-pink subconjunctival mass

✅ **B. It characteristically causes bony erosion visible on CT scan** — This is INCORRECT. Orbital lymphoma is notable for the ABSENCE of bony erosion — the lymphomatous infiltrate moulds around orbital structures without destroying bone. Bony erosion on CT should raise suspicion for lacrimal gland carcinoma, orbital metastasis, sinus malignancy with orbital extension, or myeloma — not lymphoma. All other options are correct: lymphoma is the most common primary orbital malignancy in adults; MALT is the most common subtype; the salmon patch is the classic conjunctival sign.

📚 References & Further Reading

Kanski’s Clinical Ophthalmology (9th Edition) — Chapter on Orbital Disease: Lymphoproliferative Lesions and Orbital Lymphoma
Yanoff & Duker’s Ophthalmology — Chapter on Orbital Tumours: Lymphoid Tumours and Haematological Malignancies of the Orbit
Harrison’s Principles of Internal Medicine — Chapter on Non-Hodgkin’s Lymphoma: Classification and Extranodal Disease
Robbins & Cotran Pathologic Basis of Disease — Chapter on Lymphoid Neoplasms: B-cell Lymphomas, Marginal Zone Lymphoma
Shields’ Diagnosis and Management of Orbital Tumors — Chapter on Lymphoproliferative Lesions of the Orbit and Ocular Adnexa

🚀 Ready to Master Ophthalmology?

You’ve just covered one of the highest-yield orbital oncology topics in Ophthalmology — one that integrates anatomy, pathology, immunology, and therapeutics into a single question cluster that can generate 4–6 MCQs in a single exam paper.

medicalmcq.in has 500+ free Ophthalmology MCQs — each with detailed explanations just like this article.

When you’re ready to simulate real exam pressure, our Mock Test Series gives you timed, subject-wise and full-length tests with performance analytics — so you know exactly where to focus next.

Browse Free Ophthalmology MCQs →

Try a Free Mock Test →

Orbital Lymphoma & Non-Hodgkin’s Lymphoma: Complete Guide for NEET PG, USMLE & FMGE — Ophthalmology & Oncology High-Yield Facts